EUVIMEDEUVIMED entdecken
Systematische Übersicht

Diffuse Midline H3K27-Altered Gliomas in the Spinal Cord: A Systematic Review

Gina Watanabe, Jennifer Manyu Wong, Bradley Estes, Mohammad Faizan Khan, Christian Ogasawara, Giuseppe E Umana, Allan R Martin, Orin Bloch, Paolo Palmisciano

Journal of Neuro-Oncology · 2024-02 · 166 (3) · 379-394

DOI: 10.1007/s11060-024-04584-8 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Journal of Neuro-Oncology, online erschienen am 12.02.2024. Verfasst von Gina Watanabe und 8 weiteren Autor:innen. Beteiligte Einrichtung: John A. Burns School of Medicine, University of Hawai'i, Honolulu, HI, USA. Hauptthemen laut MEDLINE: Spinal Cord Neoplasms, Glioma. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 56 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: To systematically review the clinical features, management, and outcomes of diffuse midline H3K27-altered gliomas of the spinal cord (DMG-SCs). METHODS: PubMed, Ovid EMBASE, Scopus, and Web of Science were searched from database inception to 23 September 2023 for histologically confirmed cases of DMG-SC. Patient demographics, tumor characteristics, management information, and survival outcomes were extracted and analyzed. RESULTS: A total of 279 patients from 39 studies were collected. Patients were mostly male (61%), with an average age of 32 years. Patients were treated with surgery, radiotherapy, and chemotherapy combined (31%) or surgery only (24%), and extent of resection was most often subtotal (38%). Temozolomide was the most common chemotherapeutic agent (81%). Radiation therapy was delivered with mean dose of 47 Gy in 23 fractions. At mean follow-up time of 21 months, 13% of patients were alive. Average median overall survival was 24 months (range of 13 to 40 months) with a median progression-free survival of 14 months. Historical WHO grades of 2 or 3 appeared to exhibit a longer average median overall survival time than that of grade 4 DMG-SCs (32 vs. 23 months, p = 0.009). CONCLUSIONS: Outcomes for DMG-SCs are poor overall but appear to be favorable compared to intracranial DMGs. Despite the recent WHO 2021 grade 4 classification for all DMGs, given the differences in overall survival reported based on historical grading systems, future studies on DMG-SCs are needed to further define if DMG-SCs may represent a heterogeneous group of tumors with different prognoses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Spinal Cord NeoplasmsGliomaHumansHistonesPrognosis

Stichwörter der Autor:innen

Diffuse midline gliomaIntramedullarySpinal cordSystematic reviewTumor

Substanzen

Histones

Autor:innen und Institutionen

  • John A. Burns School of Medicine, University of Hawai'i, Honolulu, HI, USA.
  • University of Kansas School of Medicine, Kansas City, KS, USA.
  • Indiana University School of Medicine, Indianapolis, IN, USA.
  • Department of Neurosurgery, University of Texas Medical Branch, Galveston, TX, USA.
  • Department of Neurosurgery, Trauma Center, Gamma Knife Center, Cannizzaro Hospital, Catania, Italy.
  • Department of Neurological Surgery, University of California, Davis, Sacramento, CA, USA.

Zitieren

APA

Watanabe, G., Wong, J. M., Estes, B., Khan, M. F., Ogasawara, C., Umana, G. E., Martin, A. R., Bloch, O., & Palmisciano, P. (2024). Diffuse Midline H3K27-Altered Gliomas in the Spinal Cord: A Systematic Review. Journal of Neuro-Oncology, 166(3), 379-394. https://doi.org/10.1007/s11060-024-04584-8

Vancouver

Watanabe G, Wong JM, Estes B, Khan MF, Ogasawara C, Umana GE, et al. Diffuse Midline H3K27-Altered Gliomas in the Spinal Cord: A Systematic Review. Journal of Neuro-Oncology. 2024;166(3):379-394. doi:10.1007/s11060-024-04584-8

BibTeX
@article{Watanabe2024,
  author = {Watanabe, Gina and Wong, Jennifer Manyu and Estes, Bradley and Khan, Mohammad Faizan and Ogasawara, Christian and Umana, Giuseppe E and Martin, Allan R and Bloch, Orin and Palmisciano, Paolo},
  title = {Diffuse Midline H3K27-Altered Gliomas in the Spinal Cord: A Systematic Review},
  journal = {Journal of Neuro-Oncology},
  year = {2024},
  volume = {166},
  number = {3},
  pages = {379--394},
  doi = {10.1007/s11060-024-04584-8}
}
Kostenlos starten →